Back to Authors

Boussetta, Sami

0000-0003-3994-6701

A5004963155 | I4210107115

Mayo Clinic

The Lymphoma Academic Research Organisation

Citations 2

Outcomes in refractory aggressive diffuse large b-cell lymphoma (DLBCL): Results from the international SCHOLAR-1 study.

Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: 7516-7516

10.1200/jco.2016.34.15_suppl.7516

Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 study

Blood | August 3, 2017 | Volume: 130 | Issue: 16 | Pages: 1800-1808

10.1182/blood-2017-03-769620 | PMID 28774879

Key Points SCHOLAR-1 is the first patient-level analysis of outcomes of refractory DLBCL from 2 large randomized trials and 2 academic databases. SCHOLAR-1 demonstrated poor outcomes in patients with refractory DLBCL, supporting a need for more effective therapies for these patients.